- 2025-09-26 10:02NFAT Inhibitor-3 841210-82-0
- 2025-09-26 10:02KRM-III 79220-94-3
- 2025-09-26 10:02INCA-6 (Triptycene-1,4-quinone) 3519-82-2
- 2025-09-26 10:02HMBPP 396726-03-7
- 2025-09-26 10:01Gomisin E 72960-21-5
- 2025-09-26 10:0111R-VIVIT TFA (Cell permeable NFAT inhibitor TFA)
- 2025-09-26 10:0111R-VIVIT (Cell permeable NFAT inhibitor) 592517-80-1
- 2025-09-26 10:01(+)-Syringaresinol ((+)-Syringaresinol) 21453-69-0
- 2025-09-26 09:26TJ-M2010-5 1357471-57-8
- 2025-09-26 09:26Pepinh-MYD 1421052-89-2
- 2025-09-26 09:26IL-1R antagonist 566914-00-9
- 2025-09-26 08:53Tasuldine 88579-39-9
- 2025-09-26 08:53S2.2 aptamer sodium
- 2025-09-26 08:53MUC5AC motif peptide (MUC5AC motif peptide) 244049-41-0
- 2025-09-26 08:53MUC1, mucin core 149205-73-2
- 2025-09-26 08:53MA3 aptamer sodium
- 2025-09-26 08:53Eudragit RS 100 33434-24-1
- 2025-09-26 08:53Ac5GalNTGc epimer 1334320-77-2
- 2025-09-26 08:53Ac5GalNTGc
- 2025-09-26 08:41Spirohexenolide A 1193347-22-6
